These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 23487470)
1. Dissociation between transmissible spongiform encephalopathy (TSE) infectivity and proteinase K-resistant PrP(Sc) levels in peripheral tissue from a murine transgenic model of TSE disease. Dobie K; Barron R J Virol; 2013 May; 87(10):5895-903. PubMed ID: 23487470 [TBL] [Abstract][Full Text] [Related]
2. High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. Barron RM; Campbell SL; King D; Bellon A; Chapman KE; Williamson RA; Manson JC J Biol Chem; 2007 Dec; 282(49):35878-86. PubMed ID: 17923484 [TBL] [Abstract][Full Text] [Related]
3. Transmissible spongiform encephalopathy strain-associated diversity of N-terminal proteinase K cleavage sites of PrP(Sc) from scrapie-infected and bovine spongiform encephalopathy-infected mice. Howells LC; Anderson S; Coldham NG; Sauer MJ Biomarkers; 2008 Jun; 13(4):393-412. PubMed ID: 18484354 [TBL] [Abstract][Full Text] [Related]
4. Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC. Vascellari S; Orrù CD; Hughson AG; King D; Barron R; Wilham JM; Baron GS; Race B; Pani A; Caughey B PLoS One; 2012; 7(11):e48969. PubMed ID: 23139828 [TBL] [Abstract][Full Text] [Related]
5. High-resolution differentiation of transmissible spongiform encephalopathy strains by quantitative N-terminal amino acid profiling (N-TAAP) of PK-digested abnormal prion protein. Gielbert A; Davis LA; Sayers AR; Hope J; Gill AC; Sauer MJ J Mass Spectrom; 2009 Mar; 44(3):384-96. PubMed ID: 19053160 [TBL] [Abstract][Full Text] [Related]
6. Scrapie infectivity and proteinase K-resistant prion protein in sheep placenta, brain, spleen, and lymph node: implications for transmission and antemortem diagnosis. Race R; Jenny A; Sutton D J Infect Dis; 1998 Oct; 178(4):949-53. PubMed ID: 9806020 [TBL] [Abstract][Full Text] [Related]
7. [Biology of non-conventional transmissible agents or prions]. Dormont D Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035 [TBL] [Abstract][Full Text] [Related]
8. Prion infectivity is encoded exclusively within the structure of proteinase K-resistant fragments of synthetically generated recombinant PrP Wang F; Wang X; Abskharon R; Ma J Acta Neuropathol Commun; 2018 Apr; 6(1):30. PubMed ID: 29699569 [TBL] [Abstract][Full Text] [Related]
9. A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Lee DC; Stenland CJ; Miller JL; Cai K; Ford EK; Gilligan KJ; Hartwell RC; Terry JC; Rubenstein R; Fournel M; Petteway SR Transfusion; 2001 Apr; 41(4):449-55. PubMed ID: 11316893 [TBL] [Abstract][Full Text] [Related]
10. Dramatic reduction of PrP C level and glycosylation in peripheral nerves following PrP knock-out from Schwann cells does not prevent transmissible spongiform encephalopathy neuroinvasion. Bradford BM; Tuzi NL; Feltri ML; McCorquodale C; Cancellotti E; Manson JC J Neurosci; 2009 Dec; 29(49):15445-54. PubMed ID: 20007469 [TBL] [Abstract][Full Text] [Related]
11. Prions of ruminants show distinct splenotropisms in an ovine transgenic mouse model. Baron T; Bencsik A; Morignat E PLoS One; 2010 Apr; 5(4):e10310. PubMed ID: 20436680 [TBL] [Abstract][Full Text] [Related]
12. Glycosylation of PrPC determines timing of neuroinvasion and targeting in the brain following transmissible spongiform encephalopathy infection by a peripheral route. Cancellotti E; Bradford BM; Tuzi NL; Hickey RD; Brown D; Brown KL; Barron RM; Kisielewski D; Piccardo P; Manson JC J Virol; 2010 Apr; 84(7):3464-75. PubMed ID: 20106922 [TBL] [Abstract][Full Text] [Related]
13. Thermostability as a highly dependent prion strain feature. Marín-Moreno A; Aguilar-Calvo P; Moudjou M; Espinosa JC; Béringue V; Torres JM Sci Rep; 2019 Aug; 9(1):11396. PubMed ID: 31388046 [TBL] [Abstract][Full Text] [Related]
14. Post-translational changes to PrP alter transmissible spongiform encephalopathy strain properties. Cancellotti E; Mahal SP; Somerville R; Diack A; Brown D; Piccardo P; Weissmann C; Manson JC EMBO J; 2013 Mar; 32(5):756-69. PubMed ID: 23395905 [TBL] [Abstract][Full Text] [Related]
15. Detection of PrP in extraneural tissues. Brown KL; Ritchie DL; McBride PA; Bruce ME Microsc Res Tech; 2000 Jul; 50(1):40-5. PubMed ID: 10871547 [TBL] [Abstract][Full Text] [Related]
16. Identification of a proteinase K resistant protein for use as an internal positive control marker in PrP Western blotting. Saunders GC; Horigan V; Tout AC; Windl O Res Vet Sci; 2007 Oct; 83(2):157-64. PubMed ID: 17336356 [TBL] [Abstract][Full Text] [Related]
17. Prion protein and species barriers in the transmissible spongiform encephalopathies. Priola SA Biomed Pharmacother; 1999; 53(1):27-33. PubMed ID: 10221165 [TBL] [Abstract][Full Text] [Related]
18. TSE strain differentiation in mice by immunohistochemical PrP(Sc) profiles and triplex Western blot. van Keulen LJ; Langeveld JP; Dolstra CH; Jacobs J; Bossers A; van Zijderveld FG Neuropathol Appl Neurobiol; 2015 Oct; 41(6):756-79. PubMed ID: 25201447 [TBL] [Abstract][Full Text] [Related]
19. Testing the possibility to protect bovine PrPC transgenic Swiss mice against bovine PrPSc infection by DNA vaccination using recombinant plasmid vectors harboring and expressing the complete or partial cDNA sequences of bovine PrPC. Müller S; Kehm R; Handermann M; Jakob NJ; Bahr U; Schröder B; Darai G Virus Genes; 2005 Mar; 30(2):279-96. PubMed ID: 15744583 [TBL] [Abstract][Full Text] [Related]
20. Fate of prions in soil: detergent extraction of PrP from soils. Cooke CM; Rodger J; Smith A; Fernie K; Shaw G; Somerville RA Environ Sci Technol; 2007 Feb; 41(3):811-7. PubMed ID: 17328187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]